Developmental delay, seizures, and behavioral disorder caused by new SETD1B mutation: A case report

2024

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.25259/jnrp_339_2024
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The article presents a clinical observation of a patient with atypical absences, myoclonia, psychomotor, and speech retardation. Whole-exome sequencing of the patient’s genetic material revealed a previously undescribed mutation in the SETD1B gene. The phenotypic picture of our case is similar to the data of patients with variants in the SETD1B gene, previously described in the scientific literature. The majority of the identified mutations occur in the catalytic domains, single-electron transfer (SET) and N-single-electron transfer (N-SET). There are only 6 cases in the RNA binding domain (RNA recognition motif), accounting for 3 exons of the gene. However, regardless of the location and type of mutation, the phenotypic manifestations of the described cases have common features. We want to draw the attention of the global scientific community for further research and a better understanding of the genotype-phenotypic correlation in SETD1B-associated nervous system disorder.